Inhibikase Therapeutics, Inc. (IKT) — Analyst estimates
Consensus analyst estimates for Inhibikase Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 500K | -0.11 | 1 |
| 2027 | 0 | -0.12 | 1 |
| 2028 | 36.74M | -0.4 | 3 |
| 2029 | 164.94M | -0.12 | 1 |
| 2030 | 279.12M | 0.45 | 1 |
Consensus analyst estimates by fiscal year.